News

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a ...
GEN - Genetic Engineering and Biotechnology News6d
Plex Research Partners with Ginkgo Bioworks to Apply AI-Based Search Engine to Drug Discovery
Part of the partners' plan is to use Plex's AI to identify potential new uses for existing treatments that can be used to ...
Contract Pharma4d
Ginkgo Bioworks Starts 2-Year WHEAT Manufacturing Program
Ginkgo Bioworks gains a $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems.
Ginkgo Bioworks, partners awarded $29M contract by ARPA-H
Ginkgo Bioworks (DNA) announced a new contract with the Advanced Research Projects Agency for Health, or ARPA-H, alongside partners Tritica ...
Longview News-Journal5d
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems Under the $29 million ...
Ginkgo Bioworks falls -4.8%
Ginkgo Bioworks (DNA) is down -4.8%, or -27c to $5.39.Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall ...
Insider Monkey13d
Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy?
In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique ...